Lactate is the negatively charged form of lactic acid, a three-carbon organic acid produced and consumed by many organisms. At the pH of blood and most living tissues, lactic acid exists almost entirely as lactate. Although the two names are often used interchangeably, the distinction matters in chemistry, physiology, and industrial processing. In humans, lactate is continually formed from the breakdown of glucose and other substrates, circulated between tissues, oxidized as fuel, and converted back into glucose.
Once commonly described as a waste product of oxygen-starved muscle, lactate is now understood as a central intermediate in metabolism. Its production supports continued energy release through glycolysis, while its transport connects cells and organs with different metabolic demands. Lactate concentrations also provide clinically important information, although an elevated concentration does not by itself establish oxygen deficiency or a particular disease. Beyond animal physiology, lactate formation underlies numerous food fermentations and supplies lactic acid for chemicals, pharmaceuticals, and biodegradable polymers.
Chemical identity, acidity, and stereochemistry
Lactic acid, systematically named 2-hydroxypropanoic acid, has the formula and the condensed structure . Loss of a proton from its carboxyl group produces lactate, . Their relative molecular masses are approximately 90.08 and 89.07, respectively. Lactate is therefore an organic ion, rather than an electrically neutral acid molecule. Sodium lactate, calcium lactate, and other lactate salts contain this anion paired with a positively charged counterion.
Lactic acid is an alpha-hydroxy acid because its hydroxyl group is attached to the carbon immediately adjacent to the carboxyl group. Its acid dissociation constant, expressed as , is approximately 3.86 in dilute aqueous solution near room temperature. The acid–base equilibrium can be written as
The Henderson–Hasselbalch relationship gives
At pH 7.4, this corresponds approximately to 3,500 lactate ions for every undissociated lactic acid molecule. More than 99.9% of the combined pool is therefore lactate under these conditions. Exact calculations use chemical activities rather than concentrations, but this approximation adequately explains the terminology used in physiology.
The second carbon atom is a stereogenic center, giving rise to two enantiomers. L-lactate has the configuration, whereas D-lactate has the configuration. Human carbohydrate metabolism predominantly produces L-lactate. D-lactate occurs in microbial metabolism and is also formed in small quantities in humans through pathways that detoxify methylglyoxal. The D/L designations describe stereochemical relationships; they are not general synonyms for the direction in which a substance rotates polarized light.
This chirality has important biological and industrial consequences. Many enzymes distinguish sharply between the two forms, so an assay designed for L-lactate may not detect D-lactate adequately. Microbial strains can produce predominantly one enantiomer or a mixture. Polymer manufacturers likewise control stereochemical composition because it affects the crystallinity, melting behavior, and mechanical properties of lactic-acid-derived plastics.
Lactic acid is highly soluble in water, while the solubility of lactate salts depends on their counterions and solid forms. Concentrated lactic acid preparations can contain oligomers formed by condensation between hydroxyl and carboxyl groups. Consequently, a commercial product described as lactic acid need not consist exclusively of isolated monomeric acid molecules; water content, concentration, and processing history affect its chemical composition.
Discovery and the changing interpretation of lactate
The Swedish chemist Carl Wilhelm Scheele isolated lactic acid from sour milk in 1780. Its name derives from the Latin word for milk, reflecting the material from which it was first characterized rather than the full range of its biological occurrence. In the early nineteenth century, Jöns Jacob Berzelius identified lactic acid in muscle material, establishing an association between the compound and animal tissues. Subsequent chemical work distinguished different forms and sources of lactic acid before their relationships were clarified through stereochemistry.
The microbial origin of souring became central to nineteenth-century debates about fermentation. In 1857, Louis Pasteur described the role of microorganisms in lactic fermentation. This work helped establish that particular fermentations were associated with the activity of living organisms rather than being merely spontaneous decomposition. Lactic fermentation thus contributed to the development of microbiology as well as to the practical control of food production.
During the early twentieth century, studies of isolated muscle connected lactate accumulation with carbohydrate breakdown, contraction, and recovery. Otto Meyerhof investigated relationships among muscle work, oxygen use, and lactic acid formation. Archibald V. Hill developed quantitative measurements of heat production during muscle activity. They shared the 1922 Nobel Prize in Physiology or Medicine for separate but complementary discoveries concerning muscle metabolism. Their experiments established essential energetic relationships, although later research revised the idea that lactate formation and removal could be explained principally through a simple oxygen-debt model.
Carl and Gerty Cori subsequently clarified how muscle carbohydrate metabolism connects with glucose production in the liver. The resulting Cori cycle placed lactate within an interorgan recycling pathway rather than treating it solely as a local end product. Isotope-tracer methods later made it possible to distinguish lactate concentration from lactate turnover and to show that substantial production and consumption occur simultaneously, including at rest.
From the 1970s and 1980s onward, physiological and tracer studies increasingly emphasized lactate exchange among tissues. George A. Brooks developed the lactate-shuttle framework, which describes lactate as a transferable metabolic intermediate and fuel. Research on membrane transporters, exercise metabolism, cardiac fuel use, and brain metabolism strengthened this interpretation. The historical change was not the discovery that lactate can sometimes be useful, but recognition that continual lactate formation, transport, and utilization are normal features of aerobic metabolism. Details of intracellular handling and signaling remain active areas of investigation, distinct from the well-established evidence for intercellular and interorgan exchange.
Formation, redox balance, and metabolic fate
The principal source of L-lactate in human tissues is glycolysis, the sequence of reactions that converts glucose to pyruvate. Glycolysis generates a net two molecules of adenosine triphosphate per glucose molecule when glucose is its starting substrate, along with reduced nicotinamide adenine dinucleotide, or NADH. Continued glycolysis requires a supply of oxidized NAD, conventionally written NAD. The enzyme lactate dehydrogenase helps maintain this supply by catalyzing the reversible reaction
The conversion of pyruvate to lactate does not itself produce additional ATP. Its immediate metabolic importance is regeneration of NAD, allowing the glyceraldehyde-3-phosphate dehydrogenase step of glycolysis to continue. This is particularly important when glycolytic flux is high or when mitochondrial oxidation cannot accommodate the rate at which reducing equivalents are generated. Mature red blood cells, which lack mitochondria, depend on glycolysis for ATP and continuously produce lactate even in oxygenated blood.
Lactate production is not confined to the absence of oxygen. Oxygen is not a substrate in the lactate dehydrogenase reaction, and appreciable lactate formation occurs in well-oxygenated tissues. The balance between lactate and pyruvate depends on substrate concentrations, cytosolic redox conditions, enzyme activity, and transport. Different lactate dehydrogenase isoenzymes have different kinetic properties, but none functions as an irreversible one-way switch between lactate production and consumption.
Lactate can be converted back to pyruvate and oxidized. Pyruvate enters the mitochondrion and can be converted to acetyl-CoA, whose carbon enters the citric acid cycle. Reducing equivalents generated through these pathways support oxidative phosphorylation. In this setting, lactate serves as an energy-rich substrate rather than an exhausted metabolic residue. Its carbon can also contribute to biosynthetic pathways through intermediates derived from pyruvate.
A second major fate is gluconeogenesis, especially in the liver and, under appropriate physiological conditions, the kidney. In the Cori cycle, lactate derived from peripheral glucose breakdown is returned to the liver and used to regenerate glucose. Converting two lactate molecules into one glucose molecule requires six high-energy phosphate equivalents, whereas glycolysis of that glucose yields two ATP. The cycle therefore transfers part of the energetic burden from glycolytic tissues to gluconeogenic organs. It also redistributes carbon; it is not the obligatory fate of every lactate molecule released by muscle.
Membrane transport and exchange between organs
Because lactate carries an electrical charge at physiological pH, its movement through the lipid interior of the cell membrane is limited. Most rapid movement across mammalian plasma membranes depends on transport proteins. The best-characterized systems are monocarboxylate transporters, especially members of the SLC16 family. MCT1 and MCT4 transport lactate together with a proton, coupling lactate exchange to the acid–base conditions on either side of the membrane.
These transporters are reversible. Their net direction depends on the combined lactate and proton gradients rather than on a permanent designation as importers or exporters. MCT1 is widely expressed and supports lactate uptake in many oxidative tissues, although it can also mediate release. MCT4 is prominent in highly glycolytic cells and has kinetic properties suited to lactate export when intracellular lactate is abundant. Accessory proteins, including basigin for MCT1 and MCT4, are important for normal localization and function at the cell surface.
The lactate-shuttle concept describes how this transport connects sites of production and use. Within skeletal muscle, fibers with high glycolytic activity may release lactate that is subsequently taken up by more oxidative fibers. Blood carries lactate between organs, making a locally produced metabolite available to tissues with different energy requirements. The heart is a particularly effective lactate consumer and can substantially increase lactate oxidation when circulating concentrations rise during exercise.
The liver and kidneys contribute to circulating lactate disposal through gluconeogenesis as well as oxidation. Their relative contributions vary with nutritional state, exercise, acid–base conditions, and disease. Lactate concentration in blood is therefore a system-level outcome, not a direct measurement of production by a single organ. A stable concentration can coexist with rapid turnover if appearance and disappearance are closely matched; conversely, concentration can rise because production increases, removal decreases, or both occur together.
The brain also exchanges lactate with blood, and lactate transport occurs between its cellular compartments. Astrocytes can produce lactate from glucose or glycogen, while neurons can take up and oxidize lactate. The astrocyte–neuron lactate-shuttle hypothesis proposes activity-dependent transfer as an important mechanism linking neural activity to energy supply. Lactate utilization by neurons is well established, but the quantitative importance and direction of transfer depend on experimental conditions and remain subjects of research. Evidence for lactate exchange does not establish that neurons universally rely on astrocyte-derived lactate instead of glucose.
Exercise, lactate thresholds, and muscle fatigue
During exercise, skeletal-muscle ATP demand can increase rapidly. Glycolysis accelerates to help meet this demand, and lactate production commonly rises. At lower or moderate workloads, increased production can be balanced by increased uptake and oxidation elsewhere. Blood lactate may consequently remain relatively stable despite a substantial increase in turnover. At higher intensities, appearance can exceed disappearance, producing a progressive rise in circulating concentration.
The term lactate threshold refers to an exercise intensity identified from changes in blood lactate during an incremental test. Several definitions are used, including the first sustained increase above baseline and a later, more pronounced rise. A fixed concentration of 4 millimoles per liter has historically been used as the “onset of blood lactate accumulation,” but it does not identify the same physiological state in every person. Maximum lactate steady state and critical-power measurements address related aspects of exercise tolerance, but their definitions and test procedures differ from those of an incremental lactate threshold.
Endurance training can increase mitochondrial content, oxidative enzyme capacity, capillary supply, and the ability to transport and use lactate. Consequently, a trained athlete may sustain a higher absolute workload before marked blood lactate accumulation occurs. This does not necessarily mean less lactate is produced under every matched condition. Changes in muscle recruitment, carbohydrate availability, transport, and oxidation all influence the observed concentration.
The traditional statement that “lactic acid causes fatigue” combines several distinct processes. At physiological pH, the relevant species is overwhelmingly lactate, and conversion of pyruvate to lactate consumes a proton in the conventional biochemical reaction. ATP hydrolysis, buffering, phosphate accumulation, ion movements, and multiple metabolic reactions jointly determine acid–base changes during intense work. Acidification can influence contractile function under some conditions, but lactate accumulation is not a sufficient explanation of fatigue. Changes in inorganic phosphate, calcium handling, potassium distribution, and neural activation also contribute.
Lactate does not account for delayed-onset muscle soreness, which develops hours after unfamiliar or strenuous exercise and is associated with tissue stress, damage, and inflammatory processes. Circulating lactate generally declines much sooner. During recovery, lactate carbon is oxidized or incorporated into glucose and glycogen. Light activity can accelerate its disappearance from blood in some circumstances by sustaining perfusion and oxidative use, but a faster fall in concentration is not by itself evidence that all components of recovery are improved. Blood lactate is an informative measure of metabolic behavior, not a universal numerical measure of fatigue, injury, or athletic ability.
Signaling, gene regulation, and the tumor microenvironment
Lactate has functions beyond serving as a carbon substrate. One established signaling mechanism involves hydroxycarboxylic acid receptor 1, also called HCAR1 or GPR81. This G-protein-coupled receptor responds to extracellular lactate and can inhibit adenylate cyclase through inhibitory G proteins. In adipose tissue, its activation suppresses lipolysis, linking extracellular lactate availability to the mobilization of stored fat. Receptor abundance and downstream effects vary among tissues, so the adipose response cannot simply be generalized to every cell type.
Lactate also changes cellular behavior indirectly through its relationship with pyruvate and the NADH/NAD system. Transport and metabolism can alter redox conditions, substrate use, and signaling pathways. Experiments investigating these effects must distinguish the lactate anion from accompanying changes in pH, sodium concentration, osmolarity, and nutrient supply. Adding lactic acid and adding sodium lactate to a culture medium can produce substantially different conditions even if the final measured lactate concentrations are similar.
An additional connection to gene regulation emerged with the description of histone lysine lactylation in 2019. Histones are proteins around which DNA is organized, and covalent modifications of their lysine residues can influence chromatin function. Lactylation adds a lactyl group to lysine and has been investigated as a connection between metabolism and gene expression. Subsequent work has identified lactylation on nonhistone proteins as well. Its biochemical routes, stereochemical forms, site-specific effects, and quantitative importance remain active research topics; an increase in lactate does not imply a uniform transcriptional response.
Lactate is particularly prominent in cancer biology. Many tumors display the Warburg effect, in which high glucose uptake and lactate formation occur despite the availability of oxygen. This pattern does not mean that all tumor mitochondria are defective or inactive. Glycolysis can support rapid metabolic flux and biosynthesis, while tumor cells may also oxidize lactate supplied by neighboring cells. Oxygen availability, blood supply, cell lineage, and oncogenic changes create substantial variation within and between tumors.
High lactate concentrations and an acidic extracellular environment frequently coexist in tumors, but their effects must be separated experimentally. Both can influence immune-cell metabolism and function. Responses differ among cytotoxic lymphocytes, regulatory T cells, and macrophages, as well as with exposure duration and nutrient conditions. These findings have motivated research into lactate transport and metabolism as therapeutic targets. Most proposed applications remain context-dependent, and metabolic observations alone do not establish that blocking lactate production or transport will be clinically beneficial.
Clinical interpretation and disorders of lactate metabolism
Blood lactate is a widely used biomarker in acute and critical care because its concentration reflects the balance between production and disposal across the body. Resting values in many laboratories are approximately 0.5–2.0 millimoles per liter, although reference intervals depend on specimen type, analytical method, and local practice. Arterial and venous concentrations are related but not identical, especially when regional production, blood flow, or sampling conditions differ.
An elevated concentration is termed hyperlactatemia. Lactic acidosis refers to lactate-associated metabolic acidosis, commonly accompanied by an increased anion gap. The terms are not interchangeable: lactate can be elevated without acidemia, and a person with substantial metabolic acidosis can have a near-normal blood pH if another acid–base disturbance is present. Thresholds used to define lactic acidosis vary, but concentrations above approximately 4–5 millimoles per liter are commonly encountered in clinical definitions when accompanied by metabolic acidosis.
A traditional classification separates type A lactic acidosis, associated with impaired tissue oxygen delivery or use, from type B, occurring without obvious systemic hypoperfusion. Type A settings include circulatory shock and severe hypoxemia. Type B associations include certain drugs or toxins, thiamine deficiency, some malignancies, and inherited metabolic disorders. The distinction is useful descriptively but is not absolute: several mechanisms can coexist, and impaired lactate removal may accompany increased production.
In sepsis, elevated lactate can reflect reduced perfusion, adrenergic stimulation of glycolysis, altered cellular metabolism, and impaired clearance. It is therefore not a specific measurement of anaerobic metabolism. Repeated measurements describe the trajectory of concentration, but a percentage decline sometimes called “lactate clearance” is not a direct measurement of physiological clearance unless turnover has been determined independently. Similarly, generalized seizures can cause a pronounced but often transient rise through intense muscle activity. Liver dysfunction can contribute by reducing disposal.
D-lactate requires separate consideration. In some people with short bowel syndrome, carbohydrates reaching the colon are fermented by bacteria into D-lactate and other products. D-lactic acidosis can be associated with episodic neurological disturbances, including altered mental status and impaired coordination. Routine clinical lactate assays generally target L-lactate and may not reveal D-lactate accumulation; specific analytical methods are required. D-lactate can also arise from normal methylglyoxal metabolism, but this ordinarily contributes a much smaller circulating pool.
Lactate-containing intravenous solutions constitute another distinct context. Lactated Ringer’s solution contains sodium lactate, not a large load of undissociated lactic acid. Metabolism of the lactate anion affects acid–base balance differently from administration of the free acid, illustrating why the chemical form and accompanying ions matter in clinical interpretation.
Measurement, tracing, and analytical limitations
Most routine clinical lactate measurements use enzymatic methods. Lactate oxidase converts L-lactate and oxygen into pyruvate and hydrogen peroxide:
The peroxide can be detected electrochemically or through a coupled color-producing reaction. Many blood-gas analyzers and portable devices use enzyme-containing electrodes, although instrument architecture and interference correction differ. Their outputs are concentrations under specified calibration conditions, not direct measurements of tissue oxygenation or total-body lactate production.
A second approach uses lactate dehydrogenase to oxidize lactate while reducing NAD to NADH. NADH absorbs ultraviolet light strongly at approximately 340 nanometers, allowing spectrophotometric quantification under suitable assay conditions. The equilibrium and reaction environment must be controlled to obtain reliable conversion. Chromatography, mass spectrometry, and stereospecific enzymatic procedures provide alternatives when separation from other metabolites or distinction between D- and L-lactate is required.
Specimen handling is important because blood cells continue metabolizing after collection. Delayed separation or analysis can increase measured lactate through ongoing glycolysis. Temperature, anticoagulant, glycolysis inhibitors, and the interval before measurement all affect sample stability. Fluoride-containing tubes do not necessarily stop glycolysis immediately, and requirements differ among analytical platforms. Recent exercise, prolonged local muscle activity, and regional sampling conditions can also influence the result independently of a systemic disorder.
Tracer studies answer questions that concentration measurements cannot. Infusion of labeled lactate, often containing stable isotopes such as carbon-13, permits estimation of rates of appearance, disappearance, oxidation, and incorporation into glucose. These calculations require assumptions about mixing, steady state, and label distribution. A metabolite pool can have a nearly unchanged concentration while substantial quantities enter and leave it each minute. Distinguishing pool size from flux is essential to interpreting lactate physiology.
Lactate can also be investigated by nuclear magnetic resonance spectroscopy and in vivo magnetic resonance spectroscopy. Its methyl protons produce a characteristic signal near 1.33 parts per million, although overlap with lipids and sequence-dependent signal behavior complicate interpretation. Hyperpolarized carbon-13 pyruvate imaging can detect rapid transfer of label into lactate, providing information about transport and enzyme-mediated exchange. That signal is not automatically equivalent to net lactate synthesis, because isotopic exchange can occur without a corresponding net accumulation.
Wearable sweat sensors extend lactate measurement beyond blood sampling. Sweat lactate depends on local gland metabolism, sweat rate, skin conditions, and device characteristics, so it is not a simple substitute for blood lactate. Analytical validation, calibration, and the physiological meaning of the sampled compartment remain separate requirements.
Microbial production, food fermentation, and ecological roles
Lactate is a major end product of microbial carbohydrate metabolism. Lactic acid bacteria include organisms in genera such as Lactococcus, Streptococcus, Leuconostoc, and multiple genera formerly grouped within Lactobacillus. In 2020, a major taxonomic revision divided that broad genus into numerous genera, including Lacticaseibacillus and Lactiplantibacillus. The functional category “lactic acid bacteria” is therefore useful in food microbiology but does not denote a single narrowly defined genus.
In homolactic fermentation, glucose is metabolized principally through glycolysis, and pyruvate is reduced to lactate. An idealized overall reaction using the neutral acid form is
This pathway yields two ATP per glucose when glucose enters the standard glycolytic sequence. Heterolactic fermentation uses different carbon-processing routes and generates lactate together with products such as ethanol or acetate and carbon dioxide. Product proportions depend on the organism, available electron acceptors, and growth conditions. Some bacteria possess distinct enzymes for D- and L-lactate production, while others can interconvert the enantiomers.
Food fermentations exploit the resulting acidification, together with other microbial activities. Yogurt production classically uses Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus, whose interactions promote growth and acid production. Falling pH destabilizes milk casein structures and contributes to gel formation. In vegetable fermentations such as sauerkraut and kimchi, microbial succession changes acidity, aroma, texture, and gas production over time. Salt concentration, temperature, oxygen exposure, and the starting microbial community shape the outcome.
Lactate formation also contributes to cheese production, sourdough fermentation, and silage preservation. Acidification inhibits many competing organisms, but fermentation does not make every material microbiologically safe under all conditions. Other organisms can consume lactate after it forms. For example, propionic acid bacteria convert lactate into products including propionate, acetate, and carbon dioxide; in Swiss-type cheeses, carbon dioxide contributes to the characteristic openings in the cheese.
In animal-associated and environmental communities, lactate is often a cross-feeding intermediate rather than a terminal product. In the intestinal microbiota, some bacteria release lactate while others convert it into short-chain fatty acids such as butyrate or propionate. The balance between production and consumption helps determine whether lactate accumulates. In the rumen, rapid fermentation of readily available carbohydrates can cause substantial lactate accumulation and acidification. Other organisms use lactate as an electron donor during processes coupled to nitrate, sulfate, or metal reduction, connecting its metabolism to broader environmental chemical cycles.
Industrial production, materials, and commercial uses
Industrial lactic acid is produced predominantly by microbial fermentation of carbohydrate feedstocks. Glucose, sucrose, starch hydrolysates, and other fermentable substrates can be converted using selected bacteria or fungi. Process performance depends on product yield, productivity, final concentration, optical purity, and the cost of nutrients and downstream separation. Strain selection or metabolic engineering can direct production toward L-lactic acid, D-lactic acid, or a desired mixture. Chemical synthesis is also possible, but conventional non-stereoselective routes generally produce a racemic mixture unless an additional resolution or asymmetric step is used.
Accumulating acid can inhibit the producing microorganism, so many fermentation processes control pH by adding a base. This produces a lactate salt in the broth. Traditional calcium-based processing generates calcium lactate, followed by acidification to release lactic acid; sulfuric acid treatment also produces calcium sulfate. Alternative recovery methods include electrodialysis, membrane separation, extraction, and ion exchange. Their environmental and economic advantages depend on energy use, reagent consumption, feedstock quality, and the purity required for the final application.
A major outlet is polylactic acid, commonly abbreviated PLA, an aliphatic polyester used in packaging, fibers, three-dimensional-printing filament, and selected medical products. High-molecular-mass PLA is often manufactured through ring-opening polymerization of lactide, a cyclic dimer derived from lactic acid. Direct polycondensation is another route, but removing water and achieving high molecular mass require careful processing. The industrial chain therefore involves distinct chemical species: lactate in fermentation broth, purified lactic acid, lactide, and the final polymer.
Stereochemistry is central to PLA properties. Polymers rich in one lactic acid configuration can crystallize, while substantial stereochemical mixing often reduces crystallinity. Blending suitable poly-L-lactide and poly-D-lactide chains can produce stereocomplex crystals with different thermal properties from those of either component alone. Molecular mass, crystallinity, additives, geometry, temperature, and moisture affect mechanical performance and degradation. PLA is not guaranteed to decompose rapidly in the ocean, in ordinary soil, or in home compost; many commercial articles require controlled industrial composting conditions for substantial breakdown within specified time frames.
Lactic acid is also used as a food acidulant and processing ingredient, while sodium and potassium lactate can contribute to moisture retention and microbial control in formulated foods. Lactate esters have separate uses: ethyl lactate, for example, is employed as a solvent. Free lactic acid is used in some cosmetic formulations because of its alpha-hydroxy-acid chemistry. The behavior of each product depends on concentration, pH, formulation, and chemical form, rather than on the shared presence of the lactate-derived carbon skeleton.
Environmental assessment of these applications requires examination of the entire production system. Renewable feedstocks can reduce reliance on fossil carbon, but fertilizer inputs, land use, fermentation energy, purification, transport, and end-of-life treatment also contribute to resource use and emissions. Bio-based origin, biodegradability, and compostability describe different attributes and are not interchangeable.